Schmidl Doreen, Schmetterer Leopold, Garhöfer Gerhard, Popa-Cherecheanu Alina
Department of Clinical Pharmacology, Medical University of Vienna , Vienna , Austria .
Curr Eye Res. 2015 Feb;40(2):201-12. doi: 10.3109/02713683.2014.906625. Epub 2014 Jun 3.
Gender medicine has been a major focus of research in recent years. The present review focuses on gender differences in the epidemiology of the most frequent ocular diseases that have been found to be associated with impaired ocular blood flow, such as age-related macular degeneration, glaucoma and diabetic retinopathy. Data have accumulated indicating that hormones have an important role in these diseases, since there are major differences in the prevalence and incidence between men and pre- and post-menopausal women. Whether this is related to vascular factors is, however, not entirely clear. Interestingly, the current knowledge about differences in ocular vascular parameters between men and women is sparse. Although little data is available, estrogen, progesterone and testosterone are most likely important regulators of blood flow in the retina and choroid, because they are key regulators of vascular tone in other organs. Estrogen seems to play a protective role since it decreases vascular resistance in large ocular vessels. Some studies indicate that hormone therapy is beneficial for ocular vascular disease in post-menopausal women. This evidence is, however, not sufficient to give any recommendation. Generally, remarkably few data are available on the role of sex hormones on ocular blood flow regulation, a topic that requires more attention in the future.
性别医学近年来一直是研究的主要焦点。本综述聚焦于与眼部血流受损相关的最常见眼病流行病学中的性别差异,如年龄相关性黄斑变性、青光眼和糖尿病视网膜病变。已有数据积累表明,激素在这些疾病中起重要作用,因为男性与绝经前和绝经后女性在患病率和发病率上存在重大差异。然而,这是否与血管因素有关尚不完全清楚。有趣的是,目前关于男性和女性眼部血管参数差异的知识很稀少。尽管可用数据很少,但雌激素、孕酮和睾酮很可能是视网膜和脉络膜血流的重要调节因子,因为它们是其他器官血管张力的关键调节因子。雌激素似乎起保护作用,因为它降低了眼部大血管的血管阻力。一些研究表明,激素疗法对绝经后女性的眼部血管疾病有益。然而,这一证据不足以给出任何建议。总体而言,关于性激素在眼部血流调节中的作用的数据非常少,这一主题在未来需要更多关注。